A recent meta-analysis reported the median duration of diabetes with PD-1/PD-L1 inhibitors as 49 days (range 5–448 days) and about 70% of the patients developed new-onset type 1 diabetes within 3 months (7). This evidence concerns the gene CD274 and diabetes mellitus.